Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Research into Cold Cancers Heating Up

Activation and expansion are essential for success in both autologous and allogeneic therapies.

Development of Gamma-Delta T-Cell Therapies

Continuous manufacturing and a quality-by-design development approach are a natural fit.

QbD for Small-Molecule Continuous Process Development

Topic

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

Articles

While this approval addresses breast cancer, olaparib in combination with durvalumab was approved by the EU in August 2024 for treatment of endometrial cancer.

Scottish Medicines Consortium Accepts AstraZeneca’s Breast Cancer Treatment

Feb. 11, 2025 marks the 10th anniversary of the International Day of Women and Girls in Science.

The 10th Anniversary of the International Day of Women and Girls in Science

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Application of AI/ML technology and a burst of M&A activity look to be shaping the future of the pharma industry.

Expanding Pharma’s Horizons Through AI and Acquisitions

Videos

Pharmaceutical Technology® sat down with Kate Coleman from Arriello to run through the major trends from 2024, including the importance of technological advances, and how these may progress in 2025.

Industry Outlook 2025: Regulating Technology for the Future

Cheryl Barton is director of PharmaVision, 

European biopharma companies are looking beyond GLP-1s.

Next-Generation Anti-Obesity Medicines

In this interview, Pharmaceutical Technology® discusses the trend of AI in pharma and how it may play out in 2025 and beyond with Ben Sidders from Biorelate.

Industry Outlook 2025: The Rising Prominence of AI in Pharma

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Increasing API and formulation complexity and new delivery strategies are driving innovations in taste-masking.

Evolving Approaches to Taste Masking 

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Hood, a pioneer of systems biology and systems medicine, shared his personal interest in starting a new peptide-based, informational-driven pharmaceutical company that would address wellness and longevity.

Systems Biology Pioneer Lee Hood Talks Precision Medicine, AI in Health, and the Next Paradigm Shift 

Webcasts

Webinar Date/Time: Tues, March 4, 2025 11:00 AM EST


Nasal Drug Delivery on the Rise: What’s Next for Pharma?

The optimization of processes for the development and manufacture of biopharmaceuticals is pivotal for producing quality products. 

Drug Development

Research into Cold Cancers Heating Up

Development of Gamma-Delta T-Cell Therapies

QbD for Small-Molecule Continuous Process Development